SHENYANG, China, Jan. 30 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, announces today that David Chen, VP of Business Development, will present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference at The Grand Hyatt hotel in New York on Tuesday, February 5, 2008 at 11:00 A.M. (Eastern).
The presentation will be audio webcast live and can be accessed on the Events section of the investors page of the 3SBio website at http://bbs.3sbio.com/en/News/ShowInfo_nnn6.aspx?ID=65 . A replay of the presentation and accompanying slides will be available on the 3SBio website until February 19, 2008.
About 3SBio Inc.
3SBio Inc. is a leading, fully integrated biotechnology company focused
on researching, developing, manufacturing and marketing biopharmaceutical
products, primarily in China. For more information, please visit 3SBio on
the web at http://www.3sbio.com .
For more information, please contact:
Kevin Teo, CFO
|SOURCE 3SBio Inc.|
Copyright©2008 PR Newswire.
All rights reserved